quinazolines has been researched along with Cardiac Failure in 208 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 176 (84.62) | 18.7374 |
| 1990's | 8 (3.85) | 18.2507 |
| 2000's | 12 (5.77) | 29.6817 |
| 2010's | 12 (5.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abelleira, E; Bueno, F; Jerkovich, F; Pitoia, F; Schmidt, A | 1 |
| Colon-Otero, G; Dakhil, S; Dueck, AC; Franco, S; Ghanem-Cañete, I; Jenkins, RB; Johnson, D; Kahanic, S; McCullough, AE; Moreno-Aspitia, A; Northfelt, D; Palmieri, FM; Patel, T; Perez, EA; Rodeheffer, R; Tenner, KS | 1 |
| Burttet, LM; Cerski, MR; Dora, JM; Maia, AL; Scheffel, RS; Siqueira, DR | 1 |
| Abbruzzi, A; Chen, C; Come, SE; Dang, CT; Hudis, CA; Iyengar, NM; Lehman, R; Lin, N; Morris, PG; Moy, B; Norton, L; Oeffinger, KC; Patil, S; Steingart, R; Winer, EP | 1 |
| Escudero-Vilaplana, V; Gonzalez-Haba, E; Ribed, A; Sanjurjo, M | 1 |
| Bartha, E; Deres, L; Eros, K; Gallyas, F; Halmosi, R; Hideg, K; Kalai, T; Lantos, J; Palfi, A; Riba, A; Sumegi, B; Toth, K | 1 |
| Gu, M; Hong, X; Liang, J; Lu, C; Sun, X; Tang, J; Wang, X; Xu, W; Yao, X; Zhong, T | 1 |
| Akgullu, C; Aksun, S; Bilgen, M; Boyacioglu, M; Demirci, B; Eryilmaz, U; Ilgenli, TF; Yalinkilinc, HS | 1 |
| Byrne, J; Ewer, MS; Koehler, M; Perez, EA; Preston, AJ; Rappold, E | 1 |
| Perez, EA | 1 |
| Bartha, E; Habon, T; Halmosi, R; Hideg, K; Kálai, T; Kalman, E; Kiss, GN; Kulcsár, G; Sumegi, B; Toth, K | 1 |
| Rowan, K | 1 |
| Bedard, PL; de Azambuja, E; Piccart-Gebhart, M; Suter, T | 1 |
| Bartha, E; Halmosi, R; Hideg, K; Kálai, T; Kereskai, L; Lantos, J; Magyar, K; Plozer, E; Solti, I; Sumegi, B; Szabados, E; Toth, K | 1 |
| Catalano, O; De Giuli, L; Della Porta, MG; Eleuteri, E; Riccardi, A; Tondini, C; Zambelli, A | 1 |
| Bartha, E; Gero, D; Halmosi, R; Hideg, K; Kalai, T; Magyar, K; Olah, G; Solti, I; Sumegi, B; Szabados, E; Szabo, A; Szabo, C; Toth, K | 1 |
| Criscitiello, C; de Azambuja, E; de Castro, G; Diaz, M; La Gerche, A; Metzger-Filho, O; Piccart-Gebhart, MJ; Saini, KS | 1 |
| Imaizumi, S; Miura, S; Saku, K; Uehara, Y; Yahiro, E | 1 |
| BRAILOVSKY, D; ESTEVEZ, E; FERNANDEZ, E; ROMERO, T | 1 |
| DATEY, KK; PANDYA, VN | 1 |
| KLEINSCHMIDT, A; LUDWIG, H | 1 |
| Maehara, K; Maruyama, Y; Oikawa, Y; Saito, T; Tamagawa, K; Yaoita, H | 1 |
| Wadman, M | 1 |
| Baughman, RP; Engel, PJ; Johnson, H; Richards, AI | 1 |
| Branca, MA | 1 |
| Deres, P; Gallyas, F; Halmosi, R; Hanto, K; Hideg, K; Kalai, T; Kulcsar, G; Palfi, A; Sumegi, B; Szabados, E; Szereday, Z; Toth, A; Toth, K | 1 |
| Duster, T | 1 |
| Carlier, J; D'Orio, V; el Allaf, D | 1 |
| Cowley, A; Hampton, JR; Hanley, SP | 1 |
| Burden, AC; Pohl, JE | 1 |
| Fishman, AP; Janicki, JS; Kinasewitz, GT; Reichek, N; Weber, KT; West, JS | 1 |
| Braunwald, E; Carabello, B; Colucci, WS; Grossman, W; Holman, BL; Malacoff, R; Wynne, J | 1 |
| Kasper, W; Kersting, F; Samosny, G; Schuster, HP | 1 |
| Andrews, V; Fishman, AP; Janicki, JS; Kinasewitz, GT; Weber, KT | 1 |
| Braunwald, E; Colucci, WS; Williams, GH | 2 |
| Bastian, BC; Hutton, I; Murray, RG; Tweddel, AC | 1 |
| Colucci, WS | 1 |
| Silke, B; Taylor, SH | 1 |
| Itoh, K; Kohya, T; Minami, S; Nishijima, H; Tsujinaga, H; Yasuda, H | 1 |
| Alfiero, R; Cocco, G; Padula, A; Rizzo, A; Strozzi, C; Tasini, MT; Urso, L | 1 |
| Awan, NA; Beattie, JM; Evenson, ME; Mason, DT; Needham, KE | 1 |
| Cocco, G; Sfrisi, C | 1 |
| Hayashi, H; Ogasawara, B; Ogawa, K; Sassa, H | 1 |
| Awan, NA; Evenson, MK; Mason, DT; Needham, KE | 2 |
| Coxon, R; Sharpe, DN | 2 |
| Brogden, RN; Kellerman, D; Romankiewicz, JA; Stanaszek, WF | 1 |
| Awan, NA; Lui, HK; Mason, DT | 1 |
| Romankiewicz, N | 1 |
| Corbett, JR; Firth, BG; Gilmore, A; Markham, RV; Pettinger, WA | 1 |
| Froer, KL; Hall, D; Rudolph, W | 1 |
| Bramlet, DA; Cobb, FR; Coleman, RE; Higginbotham, MB; Morris, KG | 1 |
| Feldman, R | 1 |
| Kawai, C; Nakajima, H; Sakurai, T; Yui, Y | 1 |
| Kaftańska, A; Paradowski, S; Szmydt, W | 1 |
| Bussmann, WD | 2 |
| Antani, JA | 1 |
| Ball, RM; Feldman, RC; Harrison, DC | 1 |
| Hagel, KJ; Netz, H; Rautenburg, HW; Röhner, G | 1 |
| Guzińska, B; Nartowicz, E | 1 |
| Berndt, H | 1 |
| Markiewicz, M; Przegaliński, J; Rumiński, W | 1 |
| Been, M; Hillis, WS | 1 |
| Elenkova, A; Kaloianova, A; Nikolov, G; Terzieva, L; Tomov, I | 2 |
| Braunwald, E; Colucci, WS; Holman, BL; Wynne, J | 1 |
| Goebel, R; Klein, W | 1 |
| Bassand, JP; Becque, O; Bernard, Y; Berthout, P; Magnin, D; Maurat, JP; Vial, Y | 1 |
| Cesari, GP; Soro, A; Sparvieri, F | 1 |
| Khomenko, VL; Pomerantsev, VP; Vasiuk, IuA | 1 |
| Cohn, JN | 1 |
| Conti, CR; Iacona, M; Mehta, J; Miles, D | 1 |
| Brunhes, G; Champoud, O; Cribier, A; Letac, B; Pasquis, P | 1 |
| Rutishauser, W | 1 |
| Barciela, R; Largo, F; Sánchez Domínguez, J; Urbina, FJ; Villa, JG | 1 |
| Bordás, I; Jávor, A; Józan, M; Kovács, S; Tarján, J; Tordasi, E; Wágner, G | 1 |
| Clarke, GM; Cope, GD; Hockings, BE; Taylor, RR | 1 |
| Gale, EV; Kuan, P; Reuben, SR; Wilde, PM | 1 |
| Forfang, K; Ihlen, H; Kjekshus, J; Thaulow, E | 1 |
| Fukaya, T; Hayashi, H; Matsui, E; Niwa, T; Oba, M; Okubo, M; Sassa, H | 1 |
| Henry, DP; Stein, L; Weinberger, MH | 1 |
| Baird, JR; Blackburn, KJ; Cambridge, D; Constantine, JW; Ghaly, MS; Hayden, ML; McIlhenny, HM; Moore, PF; Olukotun, AY; Pullman, LG; Salsburg, DS; Saxton, CA; Shevde, S; Taylor, CR | 1 |
| Benge, W; Chatterjee, K; Hiramatsu, B; Parmley, WW; Rouleau, JL | 1 |
| Gasanova, AS; Serbin, VI | 1 |
| Cody, RJ; Kluger, J; Laragh, JH | 1 |
| Amsterdam, EA; Awan, NA; Hermanovich, J; Mason, DT; Vera, Z | 1 |
| Kawai, C; Kawashita, K; Nakajima, H; Yoshida, A; Yui, Y | 1 |
| Di Benedetto, S; Labriola, S; Poggi, VM | 1 |
| Forfang, K; Ihlen, H; Kjekshus, J; Storstein, O; Thaulow, E | 1 |
| Chokshi, AB; Gomes, GI; Gould, L; Patel, S | 1 |
| Bertel, O; Bühler, FR; Burkart, F | 1 |
| Ball, RM; Feldman, RC; Harrison, DC; Jaillon, P; Kates, RE; Winchester, MA | 1 |
| Awan, NA; DeMaria, AN; Lee, G; Mason, DT | 1 |
| Awan, NA; Mason, DT | 1 |
| Elkayam, U; Frishman, W; LeJemtel, T; Mathur, M; Sonnenblick, EH; Strom, J | 1 |
| Conti, CR | 1 |
| Chatterjee, K; Parmley, WW; Ports, TA; Rubin, SA | 1 |
| Burgess, JH; Rouleau, JL; Warnica, JW | 1 |
| Amsterdam, EE; Awan, NA; Evenson, MK; Mason, DT; Needham, KE | 1 |
| Bay, WH; Desch, CE; Leier, CV; Magorien, RD; Triffon, DW; Unverferth, DV | 1 |
| González Villa, J; Menéndez Lozano, A; Sánchez Domińguez, J; Urbina Fuentes, FJ | 1 |
| Boch, H; Kuhn, H; Lösse, B | 1 |
| Arnold, S; Brundage, BH; Chatterjee, K; Chuck, L; Parmley, WW; Ports, T; Rouleau, J; Rubin, SA; Williams, RL | 1 |
| Bell, AJ; Taylor, DJ | 1 |
| Bussmann, WD; Kaltenbach, M; Lemke, R; Trompler, A | 2 |
| Kleinman, Y; Tzivoni, D | 1 |
| Menéndez Lozano, A; Sánchez Domínguez, J; Urbina Fuentes, FJ; Villa, JG | 1 |
| Coma Canella, I; López-Sendón, J | 1 |
| Bertolasi, CA; Pérez Baliño, N; Riccitelli, MA; Trongé, J; Villamayor, RM | 1 |
| Conti, CR; Mehta, J; Miles, D | 1 |
| Bellotti, G; de Mello, CP; de Moraes, V; Décourt, LV; Galiano, N; Pileggi, F; Ramires, JA | 1 |
| Bazzino, O; Cremades, E; Doval, H; Oliveri, R | 1 |
| Kawai, C; Nakajima, H; Sakurai, K; Wakabayashi, A; Yui, Y | 1 |
| Hamada, M; Kawanami, C; Konishi, T; Morimoto, Y; Nakai, K; Nakano, T; Noda, E; Takezawa, H; Yamamori, M | 1 |
| Lund-Johansen, P; Ohm, OJ; von der Lippe, G | 1 |
| Morgan, TO; Myers, JB; Walker, JN | 1 |
| Fukami, K; Fuseno, H; Haze, K; Hiramori, K; Honda, T; Ikeda, M; Saito, M; Tanaka, N; Umemoto, M | 1 |
| Bertel, O; Burkart, F | 1 |
| Bleifeld, W; Hanrath, P; Kuck, KH; Mathey, D | 1 |
| Mason, DT | 1 |
| Cannon, PJ; Escala, E; Goldman, SA; Johnson, LL; Weiss, MB | 1 |
| Atkins, FL | 1 |
| Chatterjee, K; Parmley, WW; Rubin, SA | 1 |
| Blaschke, T; Rubin, P | 1 |
| Benzing, G; Dillon, TR; Janos, GG; Kaplan, S; Meyer, RA | 1 |
| Greenberg, BH; Massie, BM | 1 |
| Cabaniss, CD | 1 |
| Bertel, O | 1 |
| Arnold, S; Baughman, RA; Benet, LZ; Chatterjee, K; Lin, ET; Williams, RL | 1 |
| Cohn, JN; Franciosa, JA; Pierpont, GL | 1 |
| Elkayam, U | 1 |
| Baughman, RA; Benet, LZ; Lin, ET | 1 |
| Anderson, S; Claxton, H; Harper, RW; Middlebrook, K; Pitt, A | 1 |
| Despas, P; Fitchett, DH; Pardy, R; Pathé, M | 1 |
| Haasis, R; Hepp, A; Kochsiek, K; Larbig, D; Liebau, G; Riegger, G; Schick, KD | 1 |
| Bossi, M; Gronda, E; Mauri, F; Rovelli, F | 1 |
| Boudoulas, H; Desch, CE; Leier, CV; Lewis, RP; Magorien, RD; Triffon, DW; Unverferth, DV | 1 |
| Fantini, F; Franchi, F; Michelucci, A; Morace, G; Porciani, MC | 1 |
| Himmler, FC; Klein, G; Kutschera, I; Sauer, E; Schmidt, G; Wirtzfeld, A | 1 |
| Bleifeld, W; Hanrath, P; Kuck, KH; Mathey, D; Zehnke, A | 1 |
| Foster, PR; Friedman, AW; McHenry, PL; Statza, J; Stein, L | 1 |
| Bílková, A; Soucek, R; Vokrouhlický, L; Votavová, M | 1 |
| Kato, M; Kinugawa, T; Kitamura, H; Kotake, H; Mashiba, H; Matsumoto, T; Miyakoda, H; Noguchi, N; Ogino, K; Osaki, S | 1 |
| Ichimura, M; Kase, H; Kubo, K; Mihara, A; Nagashima, K; Nomoto, Y; Ohno, T; Takai, H; Yamada, K; Yao, K | 1 |
| Matsumori, A; Nose, Y; Ono, K; Sasayama, S; Sato, Y; Shioi, T | 1 |
| Halawa, B | 1 |
| Brandt, D; Goebel, R; Harpf, H; Klein, W | 1 |
| Alimadadian, H; Aronow, WS; Danahy, DT; Greenfield, RS | 1 |
| Aronow, WS; Danahy, DT | 1 |
| Aronow, WS; Danahy, DT; Lurie, M; Orlando, JR | 1 |
| Aronow, WS; Hughes, D; Lurie, M; Turbow, M; Van Camp, S; Whittaker, K | 1 |
| Graham, RM; Koch-Weser, J; Pettinger, WA | 1 |
| Brundage, BH; Chatterjee, K; Gelberg, HJ; Parmley, WW; Ports, TA; Rubin, SA | 1 |
| Ball, R; Blaschke, T; Harrison, D; Jaillon, P; Kates, R; Rubin, P; Yee, YG | 1 |
| Atwell, RB | 1 |
| Awan, NA; Hermanovich, J; Mason, DT; Skinner, P; Whitcomb, C | 1 |
| Gorlin, R; Herman, MV; Meller, J; Packer, M | 2 |
| Charness, ME; Fishman, JA; Robertson, D | 1 |
| Elkayam, U; Frishman, WH; Lejemtel, TH; Mathur, M; Ribner, HS; Sonnenblick, EH; Strom, J | 1 |
| Arnold, SB; Baughman, RA; Benet, LZ; Chatterjee, K; Parmley, WW; Ports, TA; Williams, RL | 1 |
| Coma-Canella, I; Jadraque, LM; Lombera, F; Lopez-Sendon, J | 1 |
| Coma Canella, I; Lombera, F; López-Sendón, J; Martin Jadraque, L | 1 |
| Blanford, MF; Desch, CE; Leier, CV; Magorien, RD; Triffon, DW; Unverferth, DV | 1 |
| Benchimol, A; Desser, KB; Reyns, PR; Romney, D | 1 |
| Bassand, JP; Becque, O; Berthout, P; Maurat, JP; Vial, Y | 1 |
| Arnold, S; Brundage, B; Chatterjee, K; Parmley, W; Ports, TA | 1 |
| Conti, CR; Iacona, M; Mehta, J; Pepine, CJ | 1 |
| Akamatsu, T; Hirosawa, K; Kimata, S; Suzuki, A; Takahashi, S; Yamamoto, T | 1 |
| Gentili, S; Ronconi, M; Schiaroli, M; Timio, M | 1 |
| Guerricchio, G; Scandiffo, T; Veglia, L | 1 |
| Awan, NA; Mason, DT; Miller, RR | 1 |
| Straub, EJ | 1 |
| Cohn, JN; Franciosa, JA | 1 |
| Conti, CR; Feldman, RL; Iacona, M; Mehta, J; Pepine, CJ | 1 |
| Amsterdam, EA; DeMaria, AN; Laslett, LJ; Mason, DT | 1 |
| Awan, NA; Mason, DT; Miller, MP; Miller, RR; Specht, K; Vera, Z | 1 |
| Jackson, PG; Jennings, K; Jewitt, D | 1 |
| Gentili, S; Pede, S; Schiaroli, M; Timio, M | 1 |
| Awan, NA; Mason, DT; Maxwell, K; Miller, RR | 1 |
| Braunwald, E | 1 |
| Awan, NA; DeMaria, AN; Mason, DT; Maxwell, KS; Miller, RR; Neumann, A | 1 |
| Awan, NA; Mason, DT; Maxwell, KS; Miller, RR | 1 |
| Amano, M; Kanamori, T; Kinoshita, M; Shichiri, G; Takahashi, M | 1 |
| Kawai, C; Matsumori, A; Okada, I; Tominaga, M; Yamada, T | 1 |
| Hosoda, S; Kaneko, N; Kawagoe, Y; Kimata, S; Kimura, H; Konno, K; Miki, N; Nagashima, H; Sumiyoshi, T | 1 |
| Barrett, JA; Campbell, HF; Faith, WC; Kasiewski, C; Perrone, MH; Swillo, RS; Woltmann, RF | 1 |
| Braunwald, E; Colucci, WS; Wright, RF | 1 |
| Hasegawa, K; Inoue, S; Kawahara, Y; Nezuo, S; Sawayama, T; Tadaoka, S | 1 |
| Asada, S; Hirayama, A; Komamura, K; Lee, JM; Matsumura, Y; Mishima, M; Nishida, K; Ohara, T; Okazaki, Y; Yamamoto, K | 1 |
| Hasegawa, K; Inoue, S; Kakumae, S; Kawahara, Y; Nakamura, T; Nakao, M; Nezuo, S; Sawayama, T; Tadaoka, S | 1 |
| Alvarez, R; Bruno, JJ; Stephenson, RA; Strosberg, AM; Venuti, MC | 1 |
| Champoud, O; Cribier, A; Letac, B | 1 |
| Sonoki, H; Sugimoto, T; Tomaru, T; Uchida, Y | 1 |
| Chatterjee, K; Daly, PA; Kereiakes, D; Modin, G; Simonton, CA | 1 |
| Elkik, F; Grosgogeat, Y; Komajda, M; Lechat, P | 1 |
| Kakuta, Y; Kodera, T; Konishi, T; Koyama, T; Makino, K; Morimoto, Y; Nagano, K; Nakano, T; Takezawa, H; Umino, M | 1 |
| Bussmann, WD; Kaltenbach, M; Nadj, M; Reifart, N; Schmidt-Moritz, AD | 1 |
| Ishii, M; Ito, I; Ogawa, T; Sekiguchi, T; Sugishita, Y | 1 |
| Anderson, S; Chatterjee, K; Curran, D; Daly, PA; Parmley, WW; Scheinbaum, M; Viquerat, CE | 1 |
| Dargie, EN; Dargie, H; Kennedy, AC; Morgan, HG; Tilstone, WJ | 1 |
| Carmody, M; Keogh, B; Malone, D; O'Dwyer, WF | 1 |
23 review(s) available for quinazolines and Cardiac Failure
| Article | Year |
|---|---|
Cardiac toxicity of ErbB2-targeted therapies: what do we know?
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Heart; Heart Failure; Humans; Lapatinib; Quinazolines; Receptor, ErbB-2; Trastuzumab | 2008 |
Cardiac toxicity with anti-HER-2 therapies: what have we learned so far?
Topics: Adjuvants, Immunologic; Anthracyclines; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Drug Resistance, Neoplasm; ErbB Receptors; Female; Heart Failure; Humans; Lapatinib; Oxidative Stress; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Survival Rate; Trastuzumab; Ventricular Outflow Obstruction | 2009 |
Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzenesulfonates; Bevacizumab; Biomarkers; Breast Neoplasms; Cardiotoxins; Cardiovascular Diseases; Female; Heart Failure; Humans; Indoles; Lapatinib; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Quinazolines; Risk Assessment; Sorafenib; Sunitinib; Trastuzumab | 2011 |
Targeted therapies in breast cancer: are heart and vessels also being targeted?
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Breast Neoplasms; Female; Heart Failure; Humans; Lapatinib; Molecular Targeted Therapy; Quinazolines; Trastuzumab; Ventricular Dysfunction, Left | 2012 |
Chymase inhibitors.
Topics: Acetamides; Animals; Atrial Fibrillation; Azetidines; Benzoates; Cardiovascular Diseases; Chymases; Heart Failure; Humans; Hypertension; Mast Cells; Oxazoles; Pyrimidines; Quinazolines; Sulfonamides | 2013 |
Medicalisation of race.
Topics: Age Distribution; Aged; Antineoplastic Agents; Black or African American; Clinical Trials as Topic; Drug Approval; Drug Combinations; Gefitinib; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Lung Neoplasms; Middle Aged; Patents as Topic; Quinazolines; United States; United States Food and Drug Administration | 2007 |
The new inotropic phosphodiesterase inhibitors.
Topics: Aminopyridines; Amrinone; Calcium; Carbamates; Cardiotonic Agents; Cardiovascular Agents; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Quinazolines; Stimulation, Chemical; Time Factors; Xanthines | 1984 |
Vasodilator and inotropic agents in treatment of chronic cardiac failure: clinical experience and response in exercise performance.
Topics: Aerobiosis; Aminopyridines; Amrinone; Anaerobiosis; Cardiotonic Agents; Heart Failure; Hemodynamics; Humans; Hydralazine; Neurotransmitter Agents; Physical Exertion; Piperazines; Quinazolines; Sympathetic Nervous System; Vasodilator Agents | 1981 |
Clinical, hemodynamic, and neuroendocrine effects of chronic prazosin therapy for congestive heart failure.
Topics: Drug Tolerance; Heart Failure; Hemodynamics; Hormones; Humans; Neurotransmitter Agents; Prazosin; Quinazolines; Receptors, Adrenergic, alpha; Renin; Time Factors | 1981 |
Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications.
Topics: Adrenergic alpha-Antagonists; Animals; Arrhythmias, Cardiac; Child; Drug Tolerance; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hypertension; Kinetics; Lipids; Physical Exertion; Prazosin; Quinazolines; Raynaud Disease; Renin-Angiotensin System; Sympathetic Nervous System; Time Factors | 1982 |
[Old and new positive inotropic drugs: problems and controversies].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiotonic Agents; Glucagon; Glucosides; Heart Failure; Histamine; Humans; Imidazoles; Inosine; Quinazolines; Xanthines | 1984 |
[Positive inotropic therapy of cardiac failure: old and new drugs, controversies and tests].
Topics: Aminopyridines; Amrinone; Cardiac Glycosides; Cardiotonic Agents; Glucagon; Heart Failure; Histamine; Humans; Imidazoles; Inosine; Phosphodiesterase Inhibitors; Quinazolines; Sympathomimetics | 1984 |
Management of refractory congestive heart failure with prazosin.
Topics: Animals; Drug Evaluation; Drug Tolerance; Dyspnea; Echocardiography; Fatigue; Heart Failure; Hemodynamics; Humans; Hyperaldosteronism; Physical Exertion; Prazosin; Quinazolines; Receptors, Adrenergic, alpha; Time Factors; Vasodilator Agents | 1981 |
Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Heart Failure; Heart Rate; Hemodynamics; Humans; Hypertension; Kidney; Lipid Metabolism; Prazosin; Quinazolines; Regional Blood Flow; Renin-Angiotensin System | 1983 |
[Effect of vasodilator agents in chronic heart failure].
Topics: Cardiomegaly; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Phentolamine; Placebos; Prazosin; Quinazolines; Vasodilator Agents | 1981 |
Phosphodiesterase inhibitors: haemodynamic effects related to the treatment of cardiac failure.
Topics: Aminophylline; Animals; Carbamates; Heart Failure; Heart Rate; Hemodynamics; Humans; Myocardial Contraction; Phosphodiesterase Inhibitors; Quinazolines; Stimulation, Chemical | 1982 |
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
Vasodilator therapy of congestive heart failure.
Topics: Aortic Valve Insufficiency; Captopril; Dobutamine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Mitral Valve Insufficiency; Nitroglycerin; Nitroprusside; Phentolamine; Physical Exertion; Piperazines; Prazosin; Quinazolines; Time Factors; Vasodilator Agents | 1980 |
Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failure.
Topics: Animals; Asthma; Carbamates; Cardiotonic Agents; Cardiovascular Agents; Clinical Trials as Topic; Drug Evaluation; Drug Evaluation, Preclinical; Ethanolamines; Heart Failure; Hemodynamics; Humans; Hypertension; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1981 |
[Peripheral vasodilators in the treatment of heart failure].
Topics: Cardiac Output; Cardiomyopathies; Coronary Circulation; Droperidol; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitrates; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Rheumatic Heart Disease; Stroke Volume; Vasodilator Agents | 1982 |
[Use of vasodilator agents in circulatory insufficienty].
Topics: Blood Circulation; Dihydralazine; Heart Failure; Humans; Hydralazine; Nitrates; Nitroglycerin; Nitroprusside; Prazosin; Quinazolines; Vasodilator Agents | 1979 |
Drug therapy. Prazosin.
Topics: Animals; Binding Sites; Dogs; Heart Failure; Humans; Hypertension; Prazosin; Quinazolines; Rats; Vasomotor System | 1979 |
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Administration, Oral; Aminopyridines; Amrinone; Cardiotonic Agents; Coenzymes; Enoximone; Heart; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Milrinone; Nifedipine; Oxyfedrine; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Quinazolines; Ubiquinone | 1986 |
31 trial(s) available for quinazolines and Cardiac Failure
| Article | Year |
|---|---|
RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Lapatinib; Middle Aged; Neoplasm Staging; Paclitaxel; Quinazolines; Receptor, ErbB-2; Stroke Volume; Trastuzumab; Treatment Outcome; Ventricular Function, Left | 2013 |
Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Heart Failure; Humans; Lapatinib; Middle Aged; Paclitaxel; Quinazolines; Receptor, ErbB-2; Retrospective Studies; Trastuzumab; Treatment Outcome | 2013 |
Long-term vasodilator therapy with trimazosin in chronic cardiac failure.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Carbon Dioxide; Chronic Disease; Clinical Trials as Topic; Echocardiography; Female; Heart Failure; Humans; Long-Term Care; Male; Middle Aged; Oxygen; Oxygen Consumption; Physical Exertion; Piperazines; Placebos; Pulmonary Ventilation; Quinazolines; Random Allocation; Vasodilator Agents | 1980 |
[Vasodilator therapy with alpha-receptor blockaders. Acute and chronic effect of prazosin and phentolamine in congestive heart failure].
Topics: Adrenergic alpha-Antagonists; Adult; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Phentolamine; Prazosin; Quinazolines; Vasodilator Agents | 1981 |
Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
Topics: Adrenergic beta-Agonists; Blood Pressure; Cardiac Output; Heart Failure; Heart Rate; Hemodynamics; Humans; Physical Exertion; Practolol; Prazosin; Prenalterol; Pulmonary Wedge Pressure; Quinazolines; Stroke Volume | 1981 |
Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Hemodynamics; Humans; Prazosin; Proline; Quinazolines; Renin; Vasodilator Agents | 1982 |
Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Heart Failure; Heart Rate; Hemodynamics; Humans; Hypertension; Kidney; Lipid Metabolism; Prazosin; Quinazolines; Regional Blood Flow; Renin-Angiotensin System | 1983 |
Efficacy of prazosin in the management of chronic congestive heart failure: a 6-month randomized, double-blind, placebo-controlled study.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Physical Exertion; Prazosin; Quinazolines; Radionuclide Imaging; Random Allocation; Rest; Stroke Volume | 1983 |
Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: relation between clinical response and left ventricular function at rest and during exercise.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Double-Blind Method; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Physical Exertion; Prazosin; Quinazolines; Stroke Volume | 1983 |
[Clinical and polycardiographic evaluation of prazosin in the treatment of chronic congestive heart failure].
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Female; Heart Failure; Heart Function Tests; Humans; Male; Middle Aged; Myocardial Contraction; Prazosin; Quinazolines | 1984 |
[Effect of vasodilator agents in chronic heart failure].
Topics: Cardiomegaly; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Phentolamine; Placebos; Prazosin; Quinazolines; Vasodilator Agents | 1981 |
[Prazosin in arterial hypertension with cardiac insufficiency].
Topics: Adult; Aged; Cardiomegaly; Clinical Trials as Topic; Drug Therapy, Combination; Electrocardiography; Heart Failure; Heart Rate; Humans; Hypertension; Male; Middle Aged; Polythiazide; Prazosin; Quinazolines | 1980 |
Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
Topics: Aged; Aldosterone; Blood Pressure; Captopril; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Proline; Pulmonary Wedge Pressure; Quinazolines; Random Allocation; Renin; Stroke Volume; Vascular Resistance | 1982 |
[Treatment of chronic congestive failure with vasodilators (acute trial with prazosin and erythrityl tetranitrate)].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Chronic Disease; Clinical Trials as Topic; Erythrityl Tetranitrate; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Prazosin; Quinazolines; Stroke Volume; Vascular Resistance | 1982 |
Long-term therapy of heart failure with prazosin: a randomized double blind trial.
Topics: Adult; Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Echocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Heart Ventricles; Humans; Long-Term Care; Male; Middle Aged; Myocardial Infarction; Placebos; Prazosin; Quinazolines; Radionuclide Imaging; Renin | 1980 |
[Peripheral vasodilator agents in cardiology].
Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
Prazosin in the treatment of severe chronic congestive cardiac failure.
Topics: Adult; Aged; Chronic Disease; Echocardiography; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1980 |
Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure.
Topics: Aged; Chronic Disease; Clinical Trials as Topic; Drug Tolerance; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroprusside; Norepinephrine; Prazosin; Quinazolines; Renin | 1981 |
Comparative pharmacology and clinical efficacy of newer agents in treatment of heart failure.
Topics: Animals; Asthma; Carbamates; Cardiotonic Agents; Cardiovascular Agents; Clinical Trials as Topic; Drug Evaluation; Drug Evaluation, Preclinical; Ethanolamines; Heart Failure; Hemodynamics; Humans; Hypertension; Piperazines; Prazosin; Quinazolines; Vasodilator Agents | 1981 |
Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
Topics: Aged; Captopril; Coronary Disease; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Prazosin; Proline; Quinazolines | 1982 |
[Vasodilator treatment of chronic heart failure: a chronic double-blind trial with prazosin and erythrityl tetranitrate].
Topics: Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Erythrityl Tetranitrate; Female; Heart Failure; Hemodynamics; Humans; Male; Placebos; Prazosin; Quinazolines | 1981 |
[Orally active vasodilators in the management of chronic treatment-resistant cardiac failure (author's transl)].
Topics: Adult; Aged; Dihydralazine; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Middle Aged; Prazosin; Quinazolines | 1980 |
[Metazosin tablets (Kenosin) in the treatment of chronic congestive heart failure].
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Female; Heart Failure; Humans; Male; Middle Aged; Quinazolines | 1995 |
Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Physical Exertion; Piperazines; Placebos; Quinazolines; Vasodilator Agents | 1977 |
Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Heart; Heart Failure; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Physical Exertion; Piperazines; Placebos; Prazosin; Quinazolines; Vasodilator Agents | 1978 |
Effect of trimazosin on hemodynamics in chronic heart failure.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Piperazines; Placebos; Quinazolines; Vasodilator Agents | 1978 |
Effect of prazosin vs placebo on chronic left ventricular heart failure.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Physical Exertion; Placebos; Prazosin; Quinazolines; Stroke Volume | 1979 |
Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
Topics: Administration, Oral; Blood Pressure; Cardiac Output; Drug Evaluation; Drug Tolerance; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Kidney; Liver Circulation; Male; Middle Aged; Prazosin; Pulmonary Circulation; Quinazolines; Regional Blood Flow; Stroke Volume; Vascular Resistance | 1979 |
[Effect of prazosin in therapy-resistant chronic cardiac failure (author's transl)].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Cardiac Volume; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Physical Exertion; Prazosin; Pulmonary Artery; Quinazolines | 1979 |
RO 13-6438 in congestive heart failure: dose-response relationship after 3 single doses.
Topics: Administration, Oral; Aged; Aged, 80 and over; Cardiotonic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Lung; Male; Middle Aged; Quinazolines; Vascular Resistance | 1987 |
[Lack of symptomatic and long-term hemodynamic effects of prazosin in chronic heart failure. Double-blind, randomized study over one year].
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Heart Failure; Heart Valve Prosthesis; Hemodynamics; Humans; Long-Term Care; Middle Aged; Postoperative Complications; Prazosin; Quinazolines | 1985 |
158 other study(ies) available for quinazolines and Cardiac Failure
| Article | Year |
|---|---|
Rare complications of multikinase inhibitor treatment.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Carcinoma, Medullary; Female; Follow-Up Studies; Heart Failure; Humans; Intestinal Perforation; Kaplan-Meier Estimate; Male; Middle Aged; Oophoritis; Phenylurea Compounds; Piperidines; Protein Kinase Inhibitors; Quinazolines; Quinolines; Retrospective Studies; Risk Factors; Sorafenib; Thrombocytopenia; Thyroid Neoplasms; Time Factors; Young Adult | 2018 |
Toxic cardiomyopathy leading to fatal acute cardiac failure related to vandetanib: a case report with histopathological analysis.
Topics: Adult; Carcinoma, Neuroendocrine; Cardiomyopathies; Clinical Trials, Phase III as Topic; Fatal Outcome; Female; Heart Failure; Humans; Male; Piperidines; Protein Kinase Inhibitors; Quinazolines; Thyroid Neoplasms | 2013 |
Increased INR after gefitinib and acenocoumarol co-administration.
Topics: Acenocoumarol; Adenocarcinoma; Aged; Anticoagulants; Antineoplastic Agents; Atrial Fibrillation; Carcinoma, Non-Small-Cell Lung; Drug Interactions; Gefitinib; Heart Failure; Humans; International Normalized Ratio; Lung Neoplasms; Male; Protein Kinase Inhibitors; Quinazolines | 2014 |
PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms.
Topics: Animals; Blood Pressure; Extracellular Signal-Regulated MAP Kinases; Forkhead Transcription Factors; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart Failure; HSP90 Heat-Shock Proteins; Hypertension; Hypertrophy, Left Ventricular; Isoenzymes; Male; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Phosphorylation; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Kinase C; Proto-Oncogene Proteins c-akt; Quinazolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction | 2014 |
The activation of EGFR promotes myocardial tumor necrosis factor-α production and cardiac failure in endotoxemia.
Topics: Animals; Endotoxemia; ErbB Receptors; Erlotinib Hydrochloride; Heart Failure; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphorylation; Quinazolines; Signal Transduction; Tumor Necrosis Factor-alpha | 2015 |
S100A1 as a Potential Diagnostic Biomarker for Assessing Cardiotoxicity and Implications for the Chemotherapy of Certain Cancers.
Topics: Animals; Antineoplastic Agents; Biomarkers; Catalase; Glutathione; Heart Failure; Lapatinib; Male; Malondialdehyde; Myocardium; Neoplasms; Oxidative Stress; Quinazolines; Rats, Wistar; S100 Proteins; Superoxide Dismutase; Trastuzumab | 2015 |
Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Clinical Trials as Topic; Female; Heart Failure; Humans; Lapatinib; Male; Middle Aged; Neoplasms; Protein Kinase Inhibitors; Quinazolines; Stroke Volume; Ventricular Dysfunction, Left | 2008 |
Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Disease Models, Animal; Echocardiography; Enalapril; Enzyme Inhibitors; Fibrosis; Heart Failure; Male; Myocardial Infarction; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Quinazolines; Rats; Rats, Sprague-Dawley; Signal Transduction; Ventricular Remodeling | 2008 |
Trastuzumab before breast surgery? Large trial says yes but does not quell debate.
Topics: Anthracyclines; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Clinical Trials as Topic; Female; Heart; Heart Failure; Humans; Lapatinib; Neoadjuvant Therapy; Quinazolines; Receptor, ErbB-2; Trastuzumab | 2009 |
PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Topics: Administration, Oral; Animals; Blood Pressure; Cardiovascular Agents; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Male; Myocardium; Natriuretic Peptide, Brain; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Piperidines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Kinase C; Proto-Oncogene Proteins c-akt; Quinazolines; Rats; Rats, Inbred SHR; Signal Transduction; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Regulation of kinase cascade activation and heat shock protein expression by poly(ADP-ribose) polymerase inhibition in doxorubicin-induced heart failure.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Cyclic N-Oxides; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Heart Failure; HSP72 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Male; MAP Kinase Signaling System; Mice; Myocytes, Cardiac; Phosphorylation; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Quinazolines; Rats; Spin Labels | 2011 |
[2 new non-mercurial oral diuretics: quinethazone and cyclopenthiazide].
Topics: Benzothiadiazines; Cyclopenthiazide; Diuretics; Edema; Heart Failure; Liver Cirrhosis; Quinazolines; Sulfonamides | 1963 |
QUINETHAZONE AS A DIURETIC AGENT.
Topics: Blood Protein Disorders; Diuretics; Heart Failure; Humans; Kidney Diseases; Liver Cirrhosis; Quinazolines; Sulfonamides | 1963 |
[INCREASED NATRIURESIS BY MEANS OF A DIURETIC COMBINATION (QUINETHAZONE-ACETAZOLAMIDE)].
Topics: Acetazolamide; Blood Chemical Analysis; Diuretics; Erythrocytes; Heart Failure; Natriuresis; Pharmacology; Potassium; Quinazolines; Sodium; Sodium, Dietary; Sulfonamides | 1964 |
Alterations of alpha-adrenergic modulations of coronary microvascular tone in dogs with heart failure.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Flow Velocity; Cineangiography; Coronary Angiography; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Dogs; Enzyme Inhibitors; Female; Heart Failure; Injections, Intra-Arterial; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Propranolol; Quinazolines; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Vascular Resistance; Vasodilation; Yohimbine | 2005 |
Drug targeting: is race enough?
Topics: Asian People; Black or African American; Drug Combinations; Drug Industry; ErbB Receptors; Gefitinib; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Pharmacogenetics; Quinazolines; United States; United States Food and Drug Administration | 2005 |
High-output heart failure associated with anagrelide therapy for essential thrombocytosis.
Topics: Adult; Cardiac Output; Heart Failure; Humans; Male; Platelet Aggregation Inhibitors; Quinazolines; Thrombocythemia, Essential | 2005 |
BiDil raises questions about race as a marker.
Topics: Biomarkers; Black People; Clinical Trials as Topic; Dihydropyrimidine Dehydrogenase Deficiency; Dihydrouracil Dehydrogenase (NADP); Drug Approval; Drug Combinations; Drug Interactions; ErbB Receptors; Erlotinib Hydrochloride; Fluorouracil; Gefitinib; Heart Failure; Humans; Hydralazine; Isosorbide; Middle Aged; Mutation; National Institutes of Health (U.S.); Polymorphism, Genetic; Quinazolines; Risk Factors; Socioeconomic Factors; Treatment Outcome; United States; Uracil; White People | 2005 |
PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
Topics: Animals; Cardiomegaly; Collagen Type III; Electrocardiography; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart Failure; Isoproterenol; Male; Mitogen-Activated Protein Kinases; Myocardial Infarction; Natriuretic Peptide, Brain; Phosphorylation; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Kinase C; Quinazolines; Rats; Rats, Sprague-Dawley; Signal Transduction; Ventricular Remodeling | 2006 |
Danger of withdrawal of vasodilator therapy in patients with chronic heart-failure.
Topics: Acute Disease; Aged; Drug Administration Schedule; Exercise Test; Female; Heart Failure; Heart Function Tests; Heart Rate; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1980 |
Withdrawing vasodilators.
Topics: Heart Failure; Humans; Prazosin; Quinazolines; Substance Withdrawal Syndrome | 1980 |
Improved right ventricular function and reduced pulmonary vascular resistance during prazosin therapy of congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Female; Heart Failure; Heart Ventricles; Humans; Lung; Male; Middle Aged; Prazosin; Quinazolines; Vascular Resistance | 1981 |
[Interamerican symposium: Prazosin in arterial hypertension and cardiac insufficiency. Acapulco, Mexico, September 2-3, 1979].
Topics: Congresses as Topic; Heart Failure; Hypertension; Mexico; Prazosin; Quinazolines | 1980 |
The pharmacokinetic, pharmacodynamic and haemodynamic effects of acute and chronic alpha-adrenoceptor blockade in chronic heart failure.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Digoxin; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Kinetics; Male; Middle Aged; Prazosin; Quinazolines | 1981 |
[Acute effect of a new alpha 1-receptor blocking drug, E-643, on severe congestive heart failure--pharmacokinetic and hemodynamic studies].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Drug Evaluation; Female; Heart Failure; Hemodynamics; Humans; Kinetics; Male; Middle Aged; Quinazolines | 1983 |
Importance of neuroendocrine regulators of vascular tone and integral adrenoreceptor interaction during oral vasodilator therapy of severe congestive heart failure with prazosin.
Topics: Heart Failure; Hemodynamics; Humans; Muscle, Smooth, Vascular; Prazosin; Quinazolines; Receptors, Adrenergic; Vasodilator Agents | 1982 |
Plasma renin activity and plasma concentrations of norepinephrine and cyclic nucleotides in heart failure after prazosin.
Topics: Adult; Aged; Cyclic AMP; Cyclic GMP; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Prazosin; Quinazolines; Renin | 1981 |
Effects of alpha-receptor blockade with prazosin in advanced chronic congestive heart failure.
Topics: Chronic Disease; Heart Failure; Hemodynamics; Humans; Prazosin; Quinazolines; Receptors, Adrenergic, alpha; Water-Electrolyte Balance | 1983 |
New approaches to managing congestive heart failure.
Topics: Captopril; Heart Failure; Humans; Hydralazine; Prazosin; Proline; Quinazolines | 1983 |
[Captopril in chronic congestive heart failure--dose-effect behavior and comparison with prazosin].
Topics: Adult; Aged; Captopril; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Proline; Quinazolines | 1983 |
Chronic afterload reduction in the treatment of congestive heart failure.
Topics: Captopril; Drug Evaluation; Heart Failure; Humans; Hydralazine; Prazosin; Proline; Quinazolines | 1983 |
Effect of prostacyclin and prazosin in the treatment of congestive heart failure; with special reference to the sympathetic nervous system.
Topics: Blood Pressure; Epoprostenol; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Middle Aged; Norepinephrine; Platelet Aggregation; Prazosin; Quinazolines; Stroke Volume; Sympathetic Nervous System; Vascular Resistance | 1984 |
[Sustained and beneficial hemodynamic effects of prazosin in cardiac insufficiency].
Topics: Blood Pressure; Cardiac Output; Cardiomegaly; Heart Failure; Hemodynamics; Humans; Prazosin; Pulmonary Artery; Quinazolines; Time Factors | 1980 |
Prazosin for refractory cardiac failure in children.
Topics: Adolescent; Child; Child, Preschool; Chronic Disease; Heart Failure; Humans; Infant; Male; Prazosin; Quinazolines | 1984 |
[Effect of vasodilator treatment of chronic circulatory insufficiency on various polycardiographic parameters].
Topics: Chronic Disease; Drug Therapy, Combination; Female; Heart; Heart Failure; Heart Function Tests; Humans; Male; Prazosin; Quinazolines; Vasodilator Agents | 1983 |
[Prazosin (Adversuten)].
Topics: Blood Pressure; Chemical Phenomena; Chemistry; Heart Failure; Humans; Prazosin; Quinazolines; Vascular Resistance | 1983 |
[Hemodynamic effect of prazosin in patients with aortic and mitral valve insufficiency].
Topics: Adult; Aortic Valve Insufficiency; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Prazosin; Quinazolines | 1983 |
[Effects of acute and chronic vasodilator administration on hemodynamics and catecholamine concentration in chronic left heart failure (author's transl)].
Topics: Blood Pressure; Cardiac Output; Cardiomyopathies; Catecholamines; Coronary Disease; Dopamine; Epinephrine; Heart Diseases; Heart Failure; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nitroglycerin; Norepinephrine; Physical Exertion; Prazosin; Quinazolines; Vascular Resistance | 1980 |
[Hemodynamic effects of prazosin in chronic congestive heart failure].
Topics: Aged; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1980 |
[Long-term therapy with oral prazosin in chronic congestive heart failure: a clinical and echocardiographic evaluation (author's transl)].
Topics: Adult; Echocardiography; Female; Heart Failure; Humans; Long-Term Care; Male; Middle Aged; Prazosin; Quinazolines | 1980 |
Long-term maintenance therapy with prazosin in congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Dose-Response Relationship, Drug; Echocardiography; Heart Failure; Heart Rate; Humans; Long-Term Care; Middle Aged; Prazosin; Quinazolines | 1981 |
[Immediate and long-term effects of prazosin on hemodynamics in chronic cardiac insufficiency].
Topics: Adult; Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1982 |
A review of the long-term effects of prazosin and hydralazine in chronic congestive heart failure.
Topics: Chronic Disease; Drug Therapy, Combination; Follow-Up Studies; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Quinazolines; Spironolactone; Time Factors | 1983 |
[Evaluation of prazosin in chronic cardiac insufficiency by external chronometry of the left ventricle].
Topics: Adult; Aged; Drug Evaluation; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Prazosin; Quinazolines; Systole | 1983 |
[The effect of oral prazosin therapy on severe cardiac insufficiency].
Topics: Administration, Oral; Aged; Female; Heart Failure; Humans; Male; Middle Aged; Prazosin; Quinazolines; Vascular Resistance | 1983 |
Management of refractory CHF with prazosin: importance of tolerance and tachyphylaxis.
Topics: Administration, Oral; Drug Tolerance; Echocardiography; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Physical Exertion; Prazosin; Quinazolines; Tachyphylaxis | 1981 |
Haemodynamic effects of prazosin in CHF.
Topics: Cardiac Catheterization; Cardiac Output; Digoxin; Drug Therapy, Combination; Furosemide; Heart Failure; Hemodynamics; Humans; Prazosin; Quinazolines | 1981 |
Loss of prazosin effect in severe chronic CHF.
Topics: Adult; Aged; Bed Rest; Chronic Disease; Drug Tolerance; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1981 |
Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
Topics: Administration, Oral; Aged; Blood Pressure; Chronic Disease; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Renin; Vascular Resistance | 1980 |
The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Topics: Aged; Captopril; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Prazosin; Proline; Quinazolines; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Vascular Resistance | 1982 |
Cardiocirculatory actions of trimazosin and sodium nitroprusside in ischemic heart disease.
Topics: Adult; Aged; Cardiac Catheterization; Ferricyanides; Forearm; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nitroprusside; Piperazines; Plethysmography, Impedance; Quinazolines; Vasodilator Agents | 1982 |
Non-invasive radiocardiographic assessment of the effects of prazosin in congestive heart failure.
Topics: Adult; Blood Pressure; Cardiac Output; Electrocardiography; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1982 |
[Prazosin: clinical use in the treatment of arterial hypertension and cardiac insufficiency].
Topics: Heart Failure; Humans; Hypertension; Prazosin; Quinazolines | 1982 |
Effects of red rest and prazosin in congestive heart failure.
Topics: Adult; Aged; Bed Rest; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Time Factors | 1982 |
Prazosin therapy in congestive heart failure.
Topics: Administration, Oral; Heart Failure; Humans; Prazosin; Quinazolines | 1982 |
Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure.
Topics: Aged; Chronic Disease; Dizziness; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Pulmonary Wedge Pressure; Quinazolines; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1981 |
Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure.
Topics: Blood Pressure; Cardiac Output; Follow-Up Studies; Heart Failure; Heart Rate; Hemodynamics; Humans; Prazosin; Pulmonary Wedge Pressure; Quinazolines; Time Factors; Vascular Resistance | 1981 |
Ambulatory prazosin treatment of chronic congestive heart failure: development of late tolerance reversible by higher dosage and interrupted substitution therapy.
Topics: Administration, Oral; Ambulatory Care; Chronic Disease; Drug Tolerance; Forearm; Heart Failure; Hemodynamics; Humans; Plethysmography, Impedance; Prazosin; Quinazolines; Regional Blood Flow; Vascular Resistance | 1981 |
Oral vasodilator therapy with prazosin in severe congestive heart failure.
Topics: Acute Disease; Administration, Oral; Ambulatory Care; Chronic Disease; Heart Failure; Hemodynamics; Humans; Prazosin; Quinazolines; Vascular Resistance; Vasodilator Agents | 1981 |
Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
Topics: Aged; Blood Pressure; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Prazosin; Quinazolines; Vascular Resistance | 1981 |
Symposium on Congestive Heart Failure. Introduction.
Topics: Heart Failure; Humans; Prazosin; Quinazolines; Vasodilator Agents | 1981 |
Influence of oral prazosin therapy on exercise hemodynamics in patients with severe chronic heart failure.
Topics: Administration, Oral; Heart; Heart Failure; Hemodynamics; Humans; Lactates; Myocardium; Oxygen Consumption; Physical Exertion; Prazosin; Quinazolines; Vasodilator Agents | 1981 |
Prazosin and congestive heart failure: short- and long-term therapy.
Topics: Aged; Diuretics; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Time Factors; Vasodilator Agents | 1981 |
Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
Topics: Administration, Oral; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Prazosin; Quinazolines; Vascular Resistance; Vasodilator Agents | 1981 |
Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
Topics: Cardiac Output; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Kidney; Liver Circulation; Male; Middle Aged; Prazosin; Quinazolines; Regional Blood Flow; Vascular Resistance | 1981 |
[Prazosin in heart insufficiency. Short-term hospital clinical trial].
Topics: Adult; Aged; Drug Evaluation; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1981 |
[Chronic administration of prazosin in patients with congestive cardiomyopathy (author's transl)].
Topics: Adult; Chronic Disease; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1981 |
Hemodynamic effects of prazosin in chronic heart failure.
Topics: Adult; Aged; Animals; Cats; Drug Evaluation; Heart Failure; Hemodynamics; Humans; In Vitro Techniques; Middle Aged; Myocardial Contraction; Physical Exertion; Prazosin; Quinazolines; Rest | 1981 |
Treatment of refractory heart failure with trimazosin.
Topics: Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Piperazines; Quinazolines; Vasodilator Agents | 1981 |
Controlled study of long-term prazosin in refractory heart failure.
Topics: Acute Disease; Adult; Aged; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1981 |
[Prazosin in the treatment of chronic resistant heart failure].
Topics: Heart Failure; Hemodynamics; Humans; Prazosin; Quinazolines | 1981 |
[Prazosin in chronic refractory cardiac insufficiency: results of continuous long-term therapy].
Topics: Adult; Aged; Drug Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Prazosin; Prospective Studies; Quinazolines; Time Factors | 1981 |
[Comparative hemodynamic effect of sodium nitroprusside and prazosin hydrochloride in patients with cardiac insufficiency following acute myocardial infarction].
Topics: Aged; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nitroprusside; Prazosin; Quinazolines | 1981 |
[Vasodilator therapy of pump failure in acute myocardial infarction].
Topics: Adult; Aged; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroprusside; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
[Usefulness of vasodilators in congestive cardiac insufficiency: studies with prazosin].
Topics: Adult; Aged; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Nitroprusside; Prazosin; Quinazolines; Time Factors; Vasodilator Agents | 1980 |
[Echocardiographic, hemodynamic and clinical effects of prazosin in subjects with severe cardiopathy caused by Chagas disease].
Topics: Adult; Chagas Cardiomyopathy; Echocardiography; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Time Factors | 1980 |
[Acute myocardial infarction with pump failure: hemodynamic response to prazosin].
Topics: Adult; Aged; Arterioles; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
[Alterations in the sympathetic nervous activity during vasodilator therapy by nitroprusside and prazosin in patients with congestive heart failure (author's transl)].
Topics: Adult; Aged; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroprusside; Prazosin; Quinazolines; Sympathetic Nervous System | 1981 |
[Acute effects of a new antihypertensive quinazoline derivative, E-643 in severe heart failure--hemodynamics, plasma catecholamine levels and blood gas data (author's transl)].
Topics: Adult; Aged; Catecholamines; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Quinazolines | 1981 |
Acute hemodynamic and long-term clinical effects of prazosin in the treatment of chronic congestive heart failure.
Topics: Adult; Aged; Coronary Disease; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1981 |
Effect of prazosin on renal function in chronic congestive cardiac failure.
Topics: Adult; Aged; Body Weight; Creatinine; Gout; Heart Failure; Humans; Kidney; Male; Middle Aged; Prazosin; Quinazolines; Tachycardia; Urea; Vasodilator Agents | 1981 |
[The effects of prazosin in patients with chronic refractory heart failure-acute hemodynamic effects of oral prazosin and long-term therapy (author's transl)].
Topics: Administration, Oral; Adult; Aged; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1981 |
[Long-term results of vasodilator therapy with prazosin in severe refractory cardiac insufficiency].
Topics: Capillary Resistance; Heart Failure; Humans; Prazosin; Quinazolines; Time Factors | 1981 |
[Acute and chronic treatment of chronic cardiac insufficiency with nitrates or prazosin respectively].
Topics: Acute Disease; Chronic Disease; Heart Failure; Humans; Nitrates; Prazosin; Quinazolines | 1981 |
[Permanent therapy of chronic cardiac insufficiency with prazosin].
Topics: Adult; Erectile Dysfunction; Female; Heart Failure; Humans; Hypotension, Orthostatic; Male; Middle Aged; Prazosin; Quinazolines; Time Factors | 1981 |
Vasodilator therapy in congestive heart failure.
Topics: Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Prazosin; Quinazolines; Vasodilator Agents | 1981 |
Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Physical Exertion; Prazosin; Quinazolines; Radionuclide Imaging | 1980 |
New therapies in the management of congestive heart failure.
Topics: Heart Failure; Humans; Hydralazine; Prazosin; Quinazolines | 1980 |
Metabolic assessment of exercise in chronic heart failure patients treated with short-term vasodilators.
Topics: Adult; Aged; Cardiac Output; Energy Metabolism; Heart Failure; Hemodynamics; Humans; Hydralazine; Lactates; Middle Aged; Myocardium; Oxygen Consumption; Physical Exertion; Prazosin; Quinazolines | 1980 |
Prazosin protein binding in health and disease.
Topics: Adult; Blood Proteins; Erythrocytes; Female; Heart Failure; Humans; In Vitro Techniques; Kidney Failure, Chronic; Liver Cirrhosis; Male; Prazosin; Protein Binding; Quinazolines | 1980 |
Vasodilator therapy for congestive heart failure.
Topics: Adolescent; Adult; Child; Child, Preschool; Digoxin; Diuretics; Drug Therapy, Combination; Ferricyanides; Heart Failure; Humans; Infant; Nitroprusside; Prazosin; Quinazolines | 1980 |
Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis.
Topics: Adult; Aged; Aortic Valve Stenosis; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Humans; Hydralazine; Male; Middle Aged; Prazosin; Quinazolines; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1980 |
Vasodilator therapy of chronic congestive heart failure.
Topics: Ambulatory Care; Chronic Disease; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Quinazolines | 1980 |
Long-term therapy with prazosin in severe chronic congestive heart failure.
Topics: Blood Pressure; Capillary Resistance; Dyspnea; Heart Failure; Heart Rate; Humans; Prazosin; Quinazolines; Stroke Volume | 1980 |
Altered prazosin pharmacokinetics in congestive heart failure.
Topics: Adult; Aged; Female; Heart Failure; Humans; Kidney Diseases; Kinetics; Liver; Male; Metabolic Clearance Rate; Middle Aged; Prazosin; Quinazolines | 1980 |
Effect of prazosin on renal function in congestive heart failure.
Topics: Aged; Blood Pressure; Creatinine; Diuresis; Heart Failure; Humans; Kidney; Male; Middle Aged; Prazosin; Quinazolines | 1980 |
Heart rate response to oral prazosin in patients with chronic congestive heart failure.
Topics: Heart Failure; Heart Rate; Humans; Prazosin; Quinazolines | 1980 |
High-performance liquid chromatographic determination of prazosin in human plasma, whole blood and urine.
Topics: Chromatography, High Pressure Liquid; Heart Failure; Humans; Kinetics; Prazosin; Quinazolines | 1980 |
The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
Topics: Blood Pressure; Cardiac Output; Heart Failure; Hemodynamics; Humans; Prazosin; Quinazolines; Vascular Resistance | 1980 |
Effect of vasodilator drugs on exercise performance in cardiac failure. Comparison of hydralazine and prazosin.
Topics: Adult; Aged; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Oxygen Consumption; Physical Exertion; Prazosin; Quinazolines; Respiration | 1980 |
Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure.
Topics: Heart Failure; Humans; Norepinephrine; Posture; Prazosin; Quinazolines; Sympathetic Nervous System; Time Factors; Vasodilator Agents | 1980 |
[Variable acute effects of prazosin on left ventricular failure (author's transl)].
Topics: Adult; Arterioles; Blood Pressure; Cardiac Catheterization; Female; Heart Failure; Heart Ventricles; Humans; Lung; Male; Middle Aged; Prazosin; Pulmonary Artery; Quinazolines; Vascular Resistance | 1980 |
[Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
Topics: Administration, Oral; Adult; Aged; Drug Evaluation; Ferricyanides; Heart; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Nitroprusside; Prazosin; Quinazolines | 1980 |
Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure.
Topics: Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Humans; Hydralazine; Myocardial Contraction; Prazosin; Pulmonary Wedge Pressure; Quinazolines; Stroke Volume | 1980 |
[Evaluation of long-term treatment with isosorbide dinitrate and prazosin in cardiac insufficiency].
Topics: Adult; Aged; Digoxin; Drug Evaluation; Female; Furosemide; Heart Failure; Heart Rate; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Quinazolines; Time Factors | 1980 |
[Prazosin long-term treatment in severe chronic cardiac failure (author's transl)].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Chronic Disease; Digitalis Glycosides; Diuretics; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Prazosin; Pulmonary Artery; Quinazolines | 1980 |
Acute and chronic haemodynamic effects of prazosin in left ventricular failure.
Topics: Aged; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Time Factors | 1981 |
Acute hemodynamic effects of bunazosin in congestive heart failure--differing responses according to degree of cardiac dysfunction.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Female; Heart; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Wedge Pressure; Quinazolines; Stroke Volume; Vascular Resistance | 1993 |
Studies of cardiotonic agents. 8. Synthesis and biological activities of optically active 6-(4-(benzylamino)-7-quinazolinyl)-4,5-dihydro-5-methyl-3(2H)- pyridazinone (KF15232).
Topics: Animals; Aorta; Calcium; Cardiotonic Agents; Cattle; Dogs; Guinea Pigs; Heart Failure; In Vitro Techniques; Male; Molecular Conformation; Molecular Structure; Myocardial Contraction; Nucleotides, Cyclic; Phosphodiesterase Inhibitors; Quinazolines; Stereoisomerism; Trifluoperazine; Vasodilator Agents; Ventricular Pressure | 1996 |
Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; 8-Bromo Cyclic Adenosine Monophosphate; Amrinone; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 5; Heart Failure; Humans; Interleukin-1; Interleukin-6; Kinetics; Leukocytes, Mononuclear; Lipopolysaccharides; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperidines; Pyrazines; Pyridazines; Quinazolines; Quinolines; Tumor Necrosis Factor-alpha | 1996 |
[Progress in the therapy of acute and chronic cardiac insufficiency by means of systemic vasodilators. Studies with prazosin and nitroglycerin].
Topics: Blood Pressure; Catecholamines; Heart Failure; Heart Ventricles; Humans; Nitroglycerin; Prazosin; Quinazolines | 1979 |
Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure.
Topics: Aged; Blood Pressure; Cardiac Output; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Oxygen; Oxygen Consumption; Prazosin; Quinazolines; Time Factors; Vascular Resistance | 1979 |
Influence of congestive heart failure on prazosin kinetics.
Topics: Administration, Oral; Adult; Aged; Female; Half-Life; Heart Failure; Humans; Kinetics; Male; Middle Aged; Prazosin; Quinazolines; Time Factors | 1979 |
The use of alpha blockade in the treatment of congestive heart failure associated with dirofilariasis and mitral valvular incompetence.
Topics: Animals; Digoxin; Dirofilariasis; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Male; Mitral Valve Insufficiency; Prazosin; Quinazolines | 1979 |
Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Catheterization; Cardiac Output; Coronary Disease; Drug Evaluation; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Piperazines; Plethysmography; Pulmonary Circulation; Quinazolines; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1979 |
Differences in hemodynamic effects of nitroprusside and prazosin in severe chronic congestive heart failure: evidence for a direct negative chronotropic effect of prazosin.
Topics: Administration, Oral; Aged; Female; Ferricyanides; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Nitroprusside; Prazosin; Quinazolines | 1979 |
Exacerbation of angina pectoris by prazosin.
Topics: Acute Disease; Aged; Angina Pectoris; Blood Pressure; Heart Failure; Humans; Hypertension; Male; Prazosin; Quinazolines | 1979 |
Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Chronic Disease; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Time Factors; Vascular Resistance | 1979 |
Attenuation of prazosin effect on cardiac output in chronic heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Chronic Disease; Drug Administration Schedule; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Stroke Volume; Vascular Resistance | 1979 |
Use of oral prazosin hydrochloride in congestive failure following acute myocardial infarction.
Topics: Acute Disease; Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Prazosin; Quinazolines; Stroke Volume; Vascular Resistance | 1979 |
[Hemodynamic effect of prazosin in congestive cardiac insufficiency of acute degree].
Topics: Acute Disease; Adolescent; Adult; Child; Heart Failure; Hemodynamics; Humans; Middle Aged; Prazosin; Quinazolines | 1979 |
Serial hemodynamic studies during the treatment of congestive heart failure with isolated low-dose oral prazosin therapy.
Topics: Administration, Oral; Adult; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1979 |
[Hemodynamic effects of prazosin in heart failure].
Topics: Heart Failure; Hemodynamics; Humans; Prazosin; Quinazolines | 1979 |
Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
Topics: Adult; Aged; Cardiac Output; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Prazosin; Quinazolines; Vascular Resistance | 1979 |
Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.
Topics: Adult; Aged; Chronic Disease; Ferricyanides; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Nitroprusside; Prazosin; Quinazolines | 1979 |
[Vasodilator therapy with prazosin for severe congestive heart failure--hemodynamic effects of oral single administration and chronic use (author's transl)].
Topics: Administration, Oral; Adult; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Time Factors | 1979 |
[Efficacy of prazosin in severe cardiac insufficiency].
Topics: Adult; Aged; Blood Pressure; Drug Evaluation; Female; Heart Failure; Hemodynamics; Humans; Kinetocardiography; Male; Middle Aged; Prazosin; Quinazolines; Systole | 1979 |
[Echocardiographic changes in severe congestive heart failure treated with prazosin].
Topics: Aged; Drug Therapy, Combination; Echocardiography; Female; Furosemide; Heart Failure; Humans; Male; Medigoxin; Middle Aged; Prazosin; Quinazolines | 1979 |
Comparison of effects of nitroprusside and prazosin on left ventricular function and the peripheral circulation in chronic refractory congestive heart failure.
Topics: Adult; Aged; Blood Circulation; Coronary Disease; Female; Ferricyanides; Heart Failure; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Nitroprusside; Prazosin; Quinazolines | 1978 |
Clinical use of prazosin in chf.
Topics: Heart Failure; Humans; Prazosin; Quinazolines | 1978 |
Hemodynamic effects of trimazosin in patients with left ventricular failure.
Topics: Aged; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Piperazines; Quinazolines; Time Factors; Vasodilator Agents | 1978 |
Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure.
Topics: Administration, Oral; Adult; Blood Pressure; Cardiac Output; Drug Evaluation; Ferricyanides; Heart Failure; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Nitroprusside; Prazosin; Pulmonary Circulation; Quinazolines; Vascular Resistance | 1978 |
Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy.
Topics: Aged; Coronary Disease; Digitalis Glycosides; Female; Furosemide; Heart Failure; Humans; Hydralazine; Nitroprusside; Prazosin; Quinazolines; Sodium; Tachycardia | 1978 |
Clinical pharmacology and therapeutic application of prazosin in acute and chronic refractory congestive heart failure. Balanced systemic venous and arterial dilation improving pulmonary congestion and cardiac output.
Topics: Acute Disease; Arteries; Cardiac Output; Chronic Disease; Electrocardiography; Forearm; Heart Failure; Heart Ventricles; Humans; Physical Exertion; Plethysmography; Prazosin; Pulmonary Edema; Quinazolines; Vasodilation; Veins | 1978 |
Efficacy of new inotropic drugs in clinical coronary heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Parenteral; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Phonocardiography; Phosphodiesterase Inhibitors; Piperidines; Pressure; Quinazolines; Vascular Resistance | 1978 |
[Prazosin in refractory congestive heart failure].
Topics: Adult; Aged; Coronary Disease; Digitalis Glycosides; Diuretics; Heart Failure; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1978 |
Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.
Topics: Aged; Chronic Disease; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Middle Aged; Prazosin; Quinazolines; Tachyphylaxis; Time Factors | 1979 |
Effects of prazosin on forearm resistance and capacitance vessels.
Topics: Adult; Aged; Blood Pressure; Female; Forearm; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Muscle Tonus; Prazosin; Quinazolines; Regional Blood Flow; Vascular Resistance; Vasomotor System; Veins | 1977 |
Vasodilator therapy--a physiologic approach to the treatment of heart failure.
Topics: Administration, Oral; Advertising; Chronic Disease; Heart Failure; Hemodynamics; Humans; Prazosin; Quinazolines; Vasodilator Agents | 1977 |
Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodyn
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Blood Pressure; Cardiac Output; Chronic Disease; Coronary Disease; Drug Evaluation; Dyspnea; Echocardiography; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Vascular Resistance; Vasodilator Agents | 1977 |
Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
Topics: Blood Pressure; Cardiac Output; Female; Heart; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Plethysmography, Impedance; Prazosin; Quinazolines; Vascular Resistance; Vasodilator Agents | 1977 |
Increased uncoupling of beta-, beta 1- and beta 2-adrenoceptor to myocardial contraction in failing human myocardium.
Topics: Adult; Aged; Binding, Competitive; Dobutamine; Down-Regulation; Female; Heart Failure; Humans; Iodocyanopindolol; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Pindolol; Quinazolines; Receptors, Adrenergic, beta; Terbutaline | 1992 |
The effect of alpha 1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis.
Topics: Adrenergic alpha-Antagonists; Animals; Disease Models, Animal; Encephalomyocarditis virus; Enterovirus Infections; Heart Failure; Male; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Quinazolines | 1992 |
[The acute and chronic effects of bunazosin on exercise capacity estimated by the anaerobic threshold in patients with chronic congestive heart failure].
Topics: Adult; Aged; Anaerobic Threshold; Chronic Disease; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Quinazolines | 1992 |
Pharmacology of RG W-2938: a cardiotonic agent with vasodilator activity.
Topics: Analysis of Variance; Animals; Cardiotonic Agents; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Guinea Pigs; Heart Failure; Hemodynamics; In Vitro Techniques; Male; Myocardial Contraction; Pyridazines; Quinazolines; Vasodilator Agents | 1990 |
[Acute and chronic effects of bunazosin in patients with congestive heart failure].
Topics: Adrenergic alpha-Antagonists; Atrial Natriuretic Factor; Chronic Disease; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Quinazolines | 1989 |
[Acute effects of oral bunazosin-hydrochloride in acute heart failure].
Topics: Acute Disease; Administration, Oral; Adrenergic alpha-Antagonists; Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Quinazolines | 1989 |
[The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
Topics: Adrenergic alpha-Antagonists; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Quinazolines; Renin | 1989 |
Inhibitors of cyclic AMP phosphodiesterase. 3. Synthesis and biological evaluation of pyrido and imidazolyl analogues of 1,2,3,5-tetrahydro-2-oxoimidazo[2,1-b]quinazoline.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blood Platelets; Cardiotonic Agents; Dogs; Drug Evaluation; Heart Failure; Humans; Myocardium; Platelet Aggregation; Quinazolines; Structure-Activity Relationship | 1988 |
[Prazosin in the treatment of chronic cardiac insufficiency].
Topics: Adrenergic alpha-Antagonists; Arterioles; Cardiac Output; Chronic Disease; Heart Failure; Humans; Middle Aged; Prazosin; Pulmonary Wedge Pressure; Quinazolines; Time Factors; Veins | 1985 |
[Effects of prazosin, SGB-1534, dobutamine and isoproterenol on congestive heart failure in dogs].
Topics: Adrenergic alpha-Antagonists; Animals; Disease Models, Animal; Dobutamine; Dogs; Heart Failure; Hemodynamics; Isoproterenol; Prazosin; Quinazolines | 1988 |
Survival in severe left ventricular failure treated with the new nonglycosidic, nonsympathomimetic oral inotropic agents.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Cardiotonic Agents; Death, Sudden; Drug Evaluation; Enoximone; Female; Heart Failure; Humans; Imidazoles; Male; Middle Aged; Milrinone; Pyridones; Quinazolines; Retrospective Studies; Time Factors | 1987 |
[Effects of oral bunazosin hydrochloride on hemodynamic and metabolic responses to exercise (ergometer, 25W, 5 min) in patients with severe congestive heart failure].
Topics: Aged; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Metabolism; Middle Aged; Quinazolines | 1987 |
[Correlations between resting hemodynamics and exercise tolerance before and after prazosin therapy in patients with chronic congestive heart failure].
Topics: Adult; Aged; Chronic Disease; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Rest | 1985 |
RO13-6438, a new inotrope-vasodilator: systemic and coronary hemodynamic effects in congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiotonic Agents; Coronary Circulation; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Norepinephrine; Oxygen Consumption; Quinazolines; Vasodilator Agents | 1985 |
New drugs--No. 12. Metolazone (zaroxolyn).
Topics: Antihypertensive Agents; Diuretics; Dose-Response Relationship, Drug; Drug Evaluation; Edema; Heart Failure; Hypertension; Kidney Diseases; Quinazolines; Sulfonamides | 1972 |
Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure.
Topics: Administration, Oral; Antihypertensive Agents; Carbon Radioisotopes; Chromatography; Creatinine; Female; Heart Failure; Humans; Injections, Intravenous; Kidney Failure, Chronic; Kinetics; Male; Quinazolines; Time Factors | 1974 |
Clinical and biochemical evaluation of a new diuretic agent (Metolazone).
Topics: Adolescent; Adult; Aged; Diuretics; Female; Heart Failure; Humans; Hypertension; Ketones; Kidney Diseases; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Pulmonary Heart Disease; Quinazolines; Sulfonamides | 1971 |